BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 22088576)

  • 1. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
    Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
    Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
    Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.
    Dogra GK; Herson H; Hutchison B; Irish AB; Heath CH; Golledge C; Luxton G; Moody H
    J Am Soc Nephrol; 2002 Aug; 13(8):2133-9. PubMed ID: 12138146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of preventing hemodialysis catheter infections with citrate lock.
    Silva J; Antunes J; Carvalho T; Ponce P
    Hemodial Int; 2012 Oct; 16(4):545-52. PubMed ID: 22515732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
    Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
    Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.
    Nori US; Manoharan A; Yee J; Besarab A
    Am J Kidney Dis; 2006 Oct; 48(4):596-605. PubMed ID: 16997056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a gentamicin-citrate lock leads to lower catheter-related bloodstream infection rates and reduced cost of care in hemodialysis patients.
    Hussein WF; Gomez N; Sun SJ; Yu J; Yang F; Ajuria M; Abra GE; Schiller B
    Hemodial Int; 2021 Jan; 25(1):20-28. PubMed ID: 33006269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
    Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
    J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
    Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
    Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
    Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
    Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled trial.
    Bonkain F; Racapé J; Goncalvez I; Moerman M; Denis O; Gammar N; Gastaldello K; Nortier JL
    Am J Kidney Dis; 2013 Mar; 61(3):459-65. PubMed ID: 23228946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap.
    Hymes JL; Mooney A; Van Zandt C; Lynch L; Ziebol R; Killion D
    Am J Kidney Dis; 2017 Feb; 69(2):220-227. PubMed ID: 27839894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
    Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S
    J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.